3LD-10066-85017 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-26
Dose 1 — Pfizer-BioNTech
2021-02-17
Dose 2 — Pfizer-BioNTech
2021-03-03
Registered in v-safe
2021-03-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-10
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-24
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-31
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-19
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-18
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-03
Dose 3 — Pfizer-BioNTech
2022-02-17
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Contracted COVID-19

MedDRA releases: 2024-11 · check-in free text available
2022-06-03
Survey response — 6 months, dose 3
MedDRA: Constipation, Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Issues with migraines and constipation.

MedDRA releases: 2024-11 · check-in free text available
2022-06-03
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-06-07
Call 1 — Left Voicemail
2022-09-09
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-10-01
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-07
Health check-in — day 28, dose 4
Feeling: Fair

Adult check-in
2022-10-14
Health check-in — day 35, dose 4
Feeling: Fair

Adult check-in
2022-10-21
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-09
Survey response — 3 months, dose 4
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnant

MedDRA releases: 2024-11 · check-in free text available
2023-03-10
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-26	Pfizer-BioNTech
2	2021-02-17	Pfizer-BioNTech
3	2021-12-03	Pfizer-BioNTech	No
4	2022-09-09	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-06-03	Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-02-17

Symptoms: Contracted COVID-19

Release 11 — 6 months, dose 3

2022-06-03

Symptoms: Issues with migraines and constipation.

Release 12 — 3 months, dose 4

2022-12-09

Symptoms: Pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Constipation	·	·	✓
SD	COVID-19	·	·	✓
SD	Migraine	·	·	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release